Phenotypes of severe COVID-19 ARDS receiving extracorporeal membrane oxygenation.
作者信息
Zhang Joe, Whebell Stephen F, Sanderson Barney, Retter Andrew, Daly Kathleen, Paul Richard, Barrett Nicholas, Agarwal Sangita, Lams Boris E, Meadows Christopher, Terblanche Marius, Camporota Luigi
机构信息
Department of Critical Care, Guy's & St. Thomas' NHS Foundation Trust, London, UK.
Department of Critical Care, Guy's & St. Thomas' NHS Foundation Trust, London, UK.
出版信息
Br J Anaesth. 2021 Mar;126(3):e130-e132. doi: 10.1016/j.bja.2020.12.023. Epub 2020 Dec 26.
Abstract
摘要
相似文献
1
Phenotypes of severe COVID-19 ARDS receiving extracorporeal membrane oxygenation.接受体外膜肺氧合治疗的重症新型冠状病毒肺炎急性呼吸窘迫综合征的表型
Br J Anaesth. 2021 Mar;126(3):e130-e132. doi: 10.1016/j.bja.2020.12.023. Epub 2020 Dec 26.
2
Continuous EEG findings in COVID-19 patients under extracorporeal membrane oxygenation.接受体外膜肺氧合治疗的新冠肺炎患者的脑电图连续监测结果
Clin Neurophysiol. 2021 Apr;132(4):839-840. doi: 10.1016/j.clinph.2021.01.010. Epub 2021 Feb 2.
3
Clinical data of early COVID-19 cases receiving extracorporeal membrane oxygenation in Wuhan, China.中国武汉 COVID-19 早期接受体外膜肺氧合治疗的病例的临床数据。
J Clin Anesth. 2021 Feb;68:110044. doi: 10.1016/j.jclinane.2020.110044. Epub 2020 Sep 14.
4
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation: protocol for a randomised, controlled, open-label intervention, multicentre trial.COVID-19 重症肺炎患者行体外膜肺氧合治疗时细胞因子吸附：一项随机、对照、开放标签干预、多中心试验的研究方案。
BMJ Open. 2021 Jan 17;11(1):e043345. doi: 10.1136/bmjopen-2020-043345.
5
Survival after extracorporeal membrane oxygenation in severe COVID-19 ARDS: results from an international multicenter registry.重症新型冠状病毒肺炎急性呼吸窘迫综合征患者接受体外膜肺氧合治疗后的生存情况：一项国际多中心注册研究结果
Crit Care. 2021 Mar 1;25(1):90. doi: 10.1186/s13054-021-03486-9.
6
A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence.1例体外膜肺氧合作为COVID-19相关严重急性呼吸窘迫综合征挽救治疗的病例：越来越多的证据
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620957778. doi: 10.1177/2324709620957778.
7
Extracorporeal membrane oxygenation (ECMO) in patients with COVID-19: a rapid systematic review of case studies.体外膜肺氧合 (ECMO) 在 COVID-19 患者中的应用：病例研究的快速系统评价。
Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11945-11952. doi: 10.26355/eurrev_202011_23855.
8
A Patient with COVID-19 Treated with ECMO for 26 Days.一名接受体外膜肺氧合（ECMO）治疗26天的新冠肺炎患者。
J Coll Physicians Surg Pak. 2020 Oct;30(10):171-173. doi: 10.29271/jcpsp.2020.supp2.S171.
9
Organization of extracorporeal membrane oxygenation services for COVID-19.COVID-19 体外膜肺氧合服务的组织。
Asian Cardiovasc Thorac Ann. 2021 Mar;29(3):165-169. doi: 10.1177/0218492320962932. Epub 2020 Sep 30.
10
Successfully treatment of application awake extracorporeal membrane oxygenation in critical COVID-19 patient: a case report.成功应用清醒体外膜肺氧合治疗重症新型冠状病毒肺炎患者：一例报告
J Cardiothorac Surg. 2020 Dec 17;15(1):335. doi: 10.1186/s13019-020-01376-9.
引用本文的文献
1
Respiratory Support in COVID-19-Related Respiratory Failure: Lessons Learnt.COVID-19 相关呼吸衰竭的呼吸支持：经验教训。
Adv Exp Med Biol. 2024;1457:97-109. doi: 10.1007/978-3-031-61939-7_5.
2
COVID-19, ECMO, and respiratory infection: A new triad?新型冠状病毒肺炎、体外膜肺氧合与呼吸道感染：一种新的三联征？
J Card Surg. 2022 Nov;37(11):3619-3622. doi: 10.1111/jocs.16910. Epub 2022 Sep 8.
3
Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis.COVID-19 大流行的头 2 年中体外膜肺氧合的治疗结局变化：系统回顾和荟萃分析。
Crit Care. 2022 May 23;26(1):147. doi: 10.1186/s13054-022-04011-2.
4
Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study.体外膜肺氧合在重症 COVID-19 中的生存获益：一项多中心匹配队列研究。
Intensive Care Med. 2022 Apr;48(4):467-478. doi: 10.1007/s00134-022-06645-w. Epub 2022 Mar 3.
5
Clinical outcomes of intravenous immunoglobulin therapy in COVID-19 related acute respiratory distress syndrome: a retrospective cohort study.COVID-19 相关急性呼吸窘迫综合征患者静脉注射免疫球蛋白治疗的临床转归：一项回顾性队列研究。
BMC Pulm Med. 2021 Nov 8;21(1):354. doi: 10.1186/s12890-021-01717-x.
6
Identifying organ dysfunction trajectory-based subphenotypes in critically ill patients with COVID-19.识别 COVID-19 危重症患者器官功能障碍轨迹相关亚表型。
Sci Rep. 2021 Aug 5;11(1):15872. doi: 10.1038/s41598-021-95431-7.
7
Critical care outcomes from COVID-19: patients, interventions, healthcare systems and the need for core datasets.新型冠状病毒肺炎危重症护理的结局：患者、干预措施、医疗系统及核心数据集的必要性
Anaesthesia. 2021 Sep;76(9):1155-1158. doi: 10.1111/anae.15545. Epub 2021 Jul 27.
8
Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis.体外膜肺氧合治疗 COVID-19 的系统评价和荟萃分析。
Crit Care. 2021 Jun 14;25(1):211. doi: 10.1186/s13054-021-03634-1.
9
The Right Ventricle in COVID-19 Lung Injury: Proposed Mechanisms, Management, and Research Gaps.新型冠状病毒肺炎肺损伤中的右心室：提出的机制、管理及研究空白
J Cardiothorac Vasc Anesth. 2021 Jun;35(6):1568-1572. doi: 10.1053/j.jvca.2021.01.014. Epub 2021 Jan 15.
本文引用的文献
1
Differences in clinical deterioration among three sub-phenotypes of COVID-19 patients at the time of first positive test: results from a clustering analysis.首次检测呈阳性时，新冠病毒病患者三种亚表型的临床恶化差异：聚类分析结果
Intensive Care Med. 2021 Jan;47(1):113-115. doi: 10.1007/s00134-020-06236-7. Epub 2020 Oct 19.
2
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.COVID-19 患者的体外膜肺氧合支持：体外生命支持组织登记处的国际队列研究。
Lancet. 2020 Oct 10;396(10257):1071-1078. doi: 10.1016/S0140-6736(20)32008-0. Epub 2020 Sep 25.
3
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.新型冠状病毒肺炎相关的炎症风暴与患者治疗升级：一项回顾性纵向队列研究
Lancet Rheumatol. 2020 Oct;2(10):e594-e602. doi: 10.1016/S2665-9913(20)30275-7. Epub 2020 Aug 21.
4
Machine Learning Classifier Models Can Identify Acute Respiratory Distress Syndrome Phenotypes Using Readily Available Clinical Data.机器学习分类器模型可以使用现成的临床数据识别急性呼吸窘迫综合征表型。
Am J Respir Crit Care Med. 2020 Oct 1;202(7):996-1004. doi: 10.1164/rccm.202002-0347OC.
5
Clinical phenotypes of critically ill COVID-19 patients.危重症 COVID-19 患者的临床表型。
Intensive Care Med. 2020 Aug;46(8):1651-1652. doi: 10.1007/s00134-020-06120-4. Epub 2020 May 28.
6
Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study.中性粒细胞与淋巴细胞比值作为 2019 冠状病毒病患者的预后和预测因素：一项回顾性横断面研究。
J Med Virol. 2020 Nov;92(11):2573-2581. doi: 10.1002/jmv.26061. Epub 2020 Jun 9.
7
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.COVID-19 患者严重呼吸衰竭的复杂免疫失调。
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. doi: 10.1016/j.chom.2020.04.009. Epub 2020 Apr 21.
8
COVID-19 pneumonia: different respiratory treatments for different phenotypes?新冠肺炎：针对不同表型采用不同的呼吸治疗方法？
Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.
9
Applying Machine Learning to Pediatric Critical Care Data.应用机器学习于儿科重症监护数据。
Pediatr Crit Care Med. 2018 Jul;19(7):599-608. doi: 10.1097/PCC.0000000000001567.
Zotero 插件